Hansa Biopharma to attend BIO International Convention

About this update from Hansa Biopharma Ab

LUND, Sweden , June 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that Hansa's CEO Renée Aguiar-Lucander will speak at the BIO International Convention at the Boston Convention & Exhibition Center, Boston, MA , June 16-19 . Aguiar-Lucander will participate in a panel entitled "European Biotech: Unlocking Investment Opportunities" and will be available for meetings at the conference. If you are interested in meeting with Aguiar-Lucander, please contact Hansa Biopharma at  [email protected] . To learn more about Hansa Biopharma see the latest Corporate Presentation  here.  The latest investor presentation can be viewed  here .   Contacts for more information: Evan Ballantyne , Chief Financial Officer [email protected] Stephanie Kenney , VP Global Corporate Affairs [email protected] Notes to editors About Hansa Biopharma Hansa Biopharma AB is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology platform, to address serious unmet medical needs in autoimmune diseases, gene therapy and transplantation. The company's portfolio includes imlifidase, a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients and HNSA-5487, a next-generation IgG cleaving molecule with redosing potential. Hansa Biopharma is based in Lund, Sweden , and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn . ©2025 Hansa Biopharma AB. Hansa Biopharma, the beacon logo, IDEFIRIX, and IDEFIRIX flower logo are trademarks of Hansa Biopharma AB, Lund, Sweden . All rights reserved. This information was brought to you by Cision http://news.cision.com https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-attend-bio-international-convention,c4161508 The following files are available for download: View original content: https://www.prnewswire.co.uk/news-releases/hansa-biopharma-to-attend-bio-international-convention-302478768.html

View stock analysis, news, and events for Hansa Biopharma Ab